文献速递呼吸道感染

首次通过实时逆转录聚合酶链反应在胸腔积液中检出SARS-CoV-2

First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid.
PubMed 文献 · Chest · 2020-06-11

本文报告全球首例经超声引导胸腔穿刺获取的胸腔积液中,通过实时逆转录聚合酶链反应(RT-PCR)检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)阳性的病例,并详述其主要特征。胸腔积液在COVID-19中不常见,但识别这一潜在定位有助于优化诊断评估与患者管理。

要点

  • COVID-19诊断金标准为鼻咽拭子实时RT-PCR,但敏感性有限。
  • 胸部影像在诊断评估中起关键补充作用,可发现不典型表现及替代采样靶点如胸腔积液。
  • 胸腔积液在COVID-19中不常见,但识别其病毒定位有助于优化诊断与管理。

核心结论

  • 胸腔积液不是COVID-19感染的常见表现,但及时识别这一潜在病毒定位可能有助于优化诊断评估与患者管理。

研究设计与样本

  • 病例报告:描述首例经超声引导胸腔穿刺获取胸腔积液,并通过实时RT-PCR检测SARS-CoV-2阳性的病例,详述其主要特征。

主要发现

  • 首次通过实时RT-PCR在超声引导胸腔穿刺获取的胸腔积液中检测到SARS-CoV-2。
  • 胸腔积液在COVID-19患者中较少见,但已有少数患者报告胸膜受累。

临床怎么用

  • 对于COVID-19疑似患者,若存在胸腔积液,可考虑对积液进行SARS-CoV-2 RT-PCR检测以辅助诊断。
  • 胸部影像可发现不典型表现及潜在替代采样靶点(如胸腔积液),应结合影像优化诊断评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus disease 2019 (COVID-19) is a pandemic infection due to the spread of a novel coronavirus (severe acute respiratory syndrome coronavirus 2), resulting in a wide range of clinical features, from asymptomatic carriers to ARDS. The gold standard for diagnosis is nucleic acid detection by real-time reverse transcriptase-polymerase chain reaction in nasopharyngeal swabs. However, due to limitations in this technique's sensitivity, thoracic imaging plays a crucial, complementary role in diagnostic evaluation and also allows for detection of atypical findings and potential alternative targets for sampling (eg, pleural effusion). Although less common, pleural involvement has been described in a minority of patients. This report describes the first case of reverse transcriptase-polymerase chain reaction detection of severe acute respiratory syndrome coronavirus 2 in pleural fluid obtained by means of ultrasound-guided thoracentesis, and its main characteristics are detailed. Pleural effusion is not a common finding in COVID-19 infection, but a prompt recognition of this potential localization may be useful to optimize diagnostic evaluation as well as the management of these patients.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mei F, Bonifazi M, Menzo S, et al. First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid. Chest. 2020. PMID: 32534909. doi:10.1016/j.chest.2020.05.583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。